- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Sunnyvale Today
By the People, for the People
Evercore Lowers Intuitive Surgical Stock Price Target
Analysts cite concerns over the medical equipment provider's future performance.
Apr. 6, 2026 at 2:05pm
Got story updates? Submit your updates here. ›
Evercore, a leading investment bank, has lowered its price target for Intuitive Surgical (NASDAQ:ISRG) stock from $550 to $480, while maintaining a 'neutral' rating on the company. This adjustment comes as analysts reevaluate the outlook for the medical technology firm, which is known for its pioneering da Vinci surgical systems.
Why it matters
Intuitive Surgical's stock performance is closely watched as it is a bellwether for the broader medical robotics industry. The company's technology has transformed minimally invasive surgery, but faces increasing competition and regulatory scrutiny. Evercore's revised price target signals potential headwinds that could impact the company's future growth and profitability.
The details
In a research report, Evercore analysts cited a number of factors contributing to the lower price target, including increased competition, potential regulatory changes, and a more cautious outlook on the company's near-term prospects. The new $480 price target represents a potential upside of 5.14% from Intuitive Surgical's previous closing price.
- Evercore released its updated research report on Monday, April 6, 2026.
The players
Intuitive Surgical
A leading medical technology company that designs, manufactures, and services robotic-assisted surgical systems, including the popular da Vinci platform.
Evercore
A prominent investment bank that provides financial advisory and research services to corporate clients.
What’s next
Investors will be closely monitoring Intuitive Surgical's upcoming earnings report and any further updates from the company and industry analysts regarding the competitive landscape and regulatory environment.
The takeaway
Evercore's downgrade of Intuitive Surgical's stock price target reflects broader concerns about the company's ability to maintain its dominant position in the rapidly evolving medical robotics market. This news underscores the need for Intuitive Surgical to continue innovating and adapting to stay ahead of the competition.
